About KSK Diagnostics

About company

KSK Diagnostics GmbH was established in 2014 and is the first commercial developer of molecular point-of-care diagnostic assays in Hamburg. Our company is focusing on development of Point-of-Care-Tests for molecular diagnostic of infectious diseases and cancer based on our newly developed isothermal amplification technology. Furthermore, we offer highly customizable services of Nucleic Acid-based Test developments based on real-time PCR or RT-PCR, Verification & Validation studies, and product enhancement services for other companies.